|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-5-20
|
|
pubmed:abstractText |
The implantation process is closely linked to the fundamental question of the tolerance of the maternal immune system. The main objective of this study was to investigate whether different members of the transforming growth factor-beta (TGF-beta) superfamily could intervene in the first steps of embryo implantation by modulating the secretion of proimplantatory leukemia inhibitory factor (LIF) and in the tolerance of the fetal graft by regulating proinflammatory interleukin (IL)-6 secretion by human endometrial epithelium (EEC) in vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activins,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibin-beta Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/LIF protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Leukemia Inhibitory Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta2,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta3,
http://linkedlifedata.com/resource/pubmed/chemical/activin A,
http://linkedlifedata.com/resource/pubmed/chemical/activin B,
http://linkedlifedata.com/resource/pubmed/chemical/inhibin B
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1021-7401
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2005 S. Karger AG, Basel.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-63
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15905624-Activins,
pubmed-meshheading:15905624-Adolescent,
pubmed-meshheading:15905624-Adult,
pubmed-meshheading:15905624-Dose-Response Relationship, Drug,
pubmed-meshheading:15905624-Embryo Implantation,
pubmed-meshheading:15905624-Endometrium,
pubmed-meshheading:15905624-Epithelial Cells,
pubmed-meshheading:15905624-Female,
pubmed-meshheading:15905624-Humans,
pubmed-meshheading:15905624-Immune Tolerance,
pubmed-meshheading:15905624-Inhibin-beta Subunits,
pubmed-meshheading:15905624-Inhibins,
pubmed-meshheading:15905624-Interleukin-6,
pubmed-meshheading:15905624-Leukemia Inhibitory Factor,
pubmed-meshheading:15905624-Middle Aged,
pubmed-meshheading:15905624-Pregnancy,
pubmed-meshheading:15905624-Transforming Growth Factor beta,
pubmed-meshheading:15905624-Transforming Growth Factor beta1,
pubmed-meshheading:15905624-Transforming Growth Factor beta2,
pubmed-meshheading:15905624-Transforming Growth Factor beta3
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Human endometrial leukemia inhibitory factor and interleukin-6: control of secretion by transforming growth factor-beta-related members.
|
|
pubmed:affiliation |
University of Liège, Department of Medicine, Center of Immunology, Institute of Pathology CHU-B23, Liège-Sart Tilman, Belgium. sperrier@ulg.ac.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
